Bristol, United Kingdom

David Wynick

USPTO Granted Patents = 1 

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2014

Loading Chart...
1 patent (USPTO):Explore Patents

Title: David Wynick: Innovator in Therapeutic Uses of Steroidal Compounds

Introduction

David Wynick is a notable inventor based in Bristol, GB. He has made significant contributions to the field of pharmaceuticals, particularly in the development of steroidal compounds for therapeutic uses. His innovative work focuses on addressing various medical conditions, including pain management and nerve regeneration.

Latest Patents

David Wynick holds a patent for "Therapeutic uses of steroidal compounds." This patent describes a steroid derivative compound of formula (I), where one of R and R is hydroxy and the other is hydrogen, or R and R together represent oxo. The compound is useful for the prevention or treatment of pain, improving nerve regeneration after injury, and providing neuroprotection. Notably, the patent highlights particularly useful compounds such as 11-hydroxy-Δ4-androstene-3,17-dione and 11-oxo-Δ4-androstene-3,17-dione or their derivatives.

Career Highlights

David Wynick is associated with Hunter-Fleming Limited, where he continues to advance his research and development efforts. His work has garnered attention for its potential impact on medical treatments and patient care.

Collaborations

Throughout his career, David has collaborated with esteemed colleagues, including Ernst Wulfert and James Robert Murray. These partnerships have contributed to the success of his innovative projects and the advancement of therapeutic applications.

Conclusion

David Wynick's contributions to the field of steroidal compounds exemplify the importance of innovation in medicine. His patent and ongoing work at Hunter-Fleming Limited highlight his commitment to improving health outcomes through scientific research.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…